Back to search

Article

An intranasal ASO therapeutic targeting SARS-CoV-2

2021-05-18

Abstract excerpt

The COVID-19 pandemic is exacting an increasing toll worldwide, with new SARS-CoV-2 variants emerging that exhibit higher infectivity rates and that may partially evade vaccine and antibody immunity 1 . Rapid deployment of non-invasive therapeutic avenues capable of preventing infection by all SARS-CoV-2 variants could complement current vaccination efforts and help turn the tide on the COVID-19 pandemic 2 . Her...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8e1d785-5117-5287-b1b6-13e9de09b602
DOI
10.1101/2021.05.17.444397
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An intranasal ASO therapeutic targeting SARS-CoV-2DOI 10.1101/2021.05.17.444397
An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.Semantic proximity
Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionSemantic proximity
Safety and biodistribution of Nanoligomers <sup>™</sup> targeting SARS-CoV-2 genome for treatment of COVID-19Semantic proximity
Prospects for RNAi Therapy of COVID-19Semantic proximity
Antisense oligonucleotides to therapeutically target SARS-CoV-2 infectionSemantic proximity
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-BSemantic proximity
Antisense Oligonucleotide-Based Therapy of Viral InfectionsSemantic proximity
Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSVSemantic proximity
Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamstersSemantic proximity
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2Semantic proximity
Select a neighboring publication to make it the new centre.